Combination Therapy Compared With Single-Drug Therapy in Patients With Cardiac Diseases

NCT00115349 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

20

Enrollment

OTHER

Sponsor class

Stopped due to low enrollment

Conditions

Cardiovascular Diseases
Heart Diseases
Beta-Thalassemia

Interventions

DRUG: Deferoxamine
DRUG: Deferiprone (L1)

Sponsor

Carelon Research

Collaborators

[object Object]